相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors
Sarrah E. Widatalla et al.
CARCINOGENESIS (2019)
Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility
Diva S. Whalen et al.
Oncotarget (2019)
Store operated calcium entry is altered by the inhibition of receptors tyrosine kinase
Noémie Emeriau et al.
Oncotarget (2018)
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
Claudia Omarini et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells
Yongsheng Yu et al.
MOLECULAR PHARMACEUTICS (2017)
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer
Noel J. -M. Raynal et al.
CANCER RESEARCH (2016)
Two translation initiation codons direct the expression of annexin VI 64 kDa and 68 kDa isoforms
Alfonso Gonzalez-Noriega et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women
Shreya Prasad et al.
SPRINGERPLUS (2016)
Ki-67 as a prognostic marker according to breast cancer molecular subtype
Nahed A. Soliman et al.
CANCER BIOLOGY & MEDICINE (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Yi-Rong Liu et al.
BREAST CANCER RESEARCH (2016)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer
K. Hashimoto et al.
ANNALS OF ONCOLOGY (2014)
Evaluation of a 4-Protein Serum Biomarker Panel-Biglycan, Annexin-A6, Myeloperoxidase, and Protein S100-A9 (B-AMP)-for the Detection of Esophageal Adenocarcinoma
Ali H. Zaidi et al.
CANCER (2014)
βArrestin1 Regulates the Guanine Nucleotide Exchange Factor RasGRF2 Expression and the Small GTPase Rac- mediated Formation of Membrane Protrusion and Cell Motility
Xiaojie Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer
Wei Wei et al.
STEM CELLS (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
E. C. Inwald et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors
Rainelli B. Koumangoye et al.
MOLECULAR CANCER (2013)
Non-Selective Calcium Channel Blocker Bepridil Decreases Secondary Pathology in Mice after Photothrombotic Cortical Lesion
Anu Lipsanen et al.
PLOS ONE (2013)
Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy
Robert Lindner et al.
PLOS ONE (2013)
Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer
H. Anderson et al.
ANNALS OF ONCOLOGY (2011)
Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions
Amos M. Sakwe et al.
EXPERIMENTAL CELL RESEARCH (2011)
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Sunil Badve et al.
MODERN PATHOLOGY (2011)
RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation
Fernando Calvo et al.
NATURE CELL BIOLOGY (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Discovery of epigenetically silenced genes by methylated DNA lmmunoprecipitation in colon cancer cells
Filipe V. Jacinto et al.
CANCER RESEARCH (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
Anna Bergamaschi et al.
GENES CHROMOSOMES & CANCER (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model
KA Griffin et al.
HYPERTENSION (2001)
Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia
JS Chen et al.
BLOOD (2001)
Ras binding triggers ubiquitination of the Ras exchange factor Ras-GRF2
CL de Hoog et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
